FORESIGHT AUTON/S (NASDAQ:FRSX) saw unusually-strong trading volume on Thursday . Approximately 2,893,863 shares were traded during mid-day trading, an increase of 973% from the previous session’s volume of 269,813 shares.The stock last traded at $1.98 and had previously closed at $1.86.

Several brokerages recently weighed in on FRSX. Chardan Capital reiterated a “hold” rating on shares of Assembly Biosciences in a research report on Sunday, June 30th. ValuEngine cut Zumiez from a “hold” rating to a “sell” rating in a research report on Tuesday, July 2nd.

The stock’s 50-day moving average is $1.24.

FORESIGHT AUTON/S (NASDAQ:FRSX) last announced its quarterly earnings results on Wednesday, May 15th. The company reported ($0.13) earnings per share for the quarter.

An institutional investor recently bought a new position in FORESIGHT AUTON/S stock. Psagot Investment House Ltd. acquired a new stake in FORESIGHT AUTON/S (NASDAQ:FRSX) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 552,934 shares of the company’s stock, valued at approximately $746,000. Psagot Investment House Ltd. owned 2.52% of FORESIGHT AUTON/S at the end of the most recent quarter. 2.10% of the stock is currently owned by hedge funds and other institutional investors.

FORESIGHT AUTON/S Company Profile (NASDAQ:FRSX)

Foresight Autonomous Holdings Ltd., a technology company, designs, develops, and commercializes stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry in Israel. It develops advanced driver assistance systems for accident prevention, which are designed to provide real-time information about a vehicle's surroundings while in motion.

See Also: What are some reasons analysts would give stocks a buy rating?

Receive News & Ratings for FORESIGHT AUTON/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FORESIGHT AUTON/S and related companies with MarketBeat.com's FREE daily email newsletter.